chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two days after receiving vaccine patient noticed a circular, raised, red area approximately 1 and 1/2 inches in diameter that itched and felt warm.
Adverse effects were Covid-19 like symptoms that consisted of; foggy brain, extreme thirst, chills, shakes, cold, fever, body aches, loss of taste and extreme exhaustion.
Began complaining of tingling of lips, throat and then tongue 10 minutes after receiving vaccines. Benadryl 50mg IM given. Blood pressure 122/86, pulse 60, respiration 15. Rested and recovered. Left health department with employer after 1 hour.  Nurse follow up on 07/27/04 states: "numbness of lips, tingling of tongue."
11x6 cm tender, red, and warm left thigh, Amox 250 200ml 2tsp BID.
mom states that pt recv vax 13MAR96 @ clinic & when mom went home pt had sz & convuls;mom took pt to hosp;
pt recv vax 9AUG95 & MD indicated that the pt devel a gen erythematous papular rash w/in the 1st 24hr of vax;tx w/DPH;MOC informed MD that pt recovered from the rash on 13AUG95
Covid-19; Covid-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 63-year-old male patient received BNT162b2 (BNT162B2), on 04Jan2021 as dose 1, single (Lot number: EL9262), on 25Jan2021 as dose 2, single (Lot number: EL1284) and on 02Oct2021 at 10:00 as dose 3 (booster), single (Lot number: FF2587) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "Ulcerative colitis" (unspecified if ongoing). Concomitant medication(s) included: VALSARTAN; AMLODIPINE; MESALAMINE. Past drug history included: Ace inhibitor, reaction(s): "Known allergies: Cough"; Ace inhibitor, reaction(s): "Known allergies: Cough". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 18May2022, outcome "not recovered" and all described as "Covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (18May2022) Positive, notes: Initial positive; (25May2022) Negative; (31May2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.; Sender's Comments: Based on the available information in the case, the causal association between the events vaccination failure, covid-19 and the suspect drug BNT162B2 cannot be excluded.
local rxn, red, tender, swollen;large 5inch bright red area on lt arm @ inj site;
Heaviness in both calves that moved up to back of leg (specifically right leg and included slight localized discomfort in area of leg with prominent varicose veins), and now also feeling heaviness in the muscle along either side of the spine /back.  Progression occurred over the course of about 45 minutes to one hour.
tightness of the throat; confusion; dizziness; This is a spontaneous report from a contactable other HCP (Patient). A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 02Feb2021 1st dose, single dose for covid-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced tightness of the throat, confusion, and dizziness on an unspecified date in Feb2021. Therapeutic measures were taken for tightness of the throat with 2 Benadryl after 30 minutes. The patient was recovered from the event tightness of the throat on an unspecified date in Feb2021 and outcome was unknown for the events confusion and dizziness.    No follow-up attempts are possible. No further information is expected.
Received anthrax shot morning, by evening vaccination site had turned red, warm to touch, swelling, turned to ache in joints by Sunday morning. Sought care Tues 4/17 and was diagnosed with arthus reaction, tx with ice x 2 and ibuprofen and some improvement seen Wed morning.
pt recvd vax & exp hives starting on face-spread to body-itching; seen @ clinic eyes swollen given Adrenalin & DPH;
1. Redness, itching, swelling at the injection site. 2. Armpit swelling and pain/tenderness
Prior to my visit to the hospital this past October 18, 2016 to visit my primary care physician Dr. at Clinic, and after receiving the flu vaccine and the Tdap vaccine on that visit, I felt in perfect health. As the evening of Oct 18th approached I could feel the onset of body chills. By the morning of Oct 19th I had chills, headache and a fever that rose to 102 degrees. By Friday, Oct 21st, The headache, chills and fever had subsided but was replaced by a sore throat and, most troubling, by burning/pins-and-needles sensations in my left hand finger tips. By Saturday the sore throat continued and the burning/pins-and-needles sensation in the finger tips of my left hand was now also in my right hand and beginning in the toes of both feet. Yesterday, Oct 22, I still had the minor sore throat and I still had the sensation of painful/burning sensation in the finger tips of both hands and the toes and balls of both feet and visible were small red spots, some almost blister like in appearance. This morning, Sunday Oct 23, I still have the same symptoms as yesterday but they seem to be somewhat lessened. I feel that my symptoms are a direct result of the vaccines that I were administered at the clinic on Oct 18th.
IMMEDIATELY AFTER RECEVING VACCINATION PATIENT WAS BREATHING VERY HARD FEELING DROSWY AND DIZZY. 2 DAYS AFTER WHICH IS  04/21/23  . PATIENT IS FEELING VERY PAINFUL RASH, SWOLLEN ARM
A spontaneous report has been received from a health professional. The report concerns a female patient (age 34 years, height 66 in). No medical history was reported. No concomitant products were reported. The patient received FLUMIST QUADRIVALENT (intranasal) 0.2 ml once/single administration, via nasal route, for for flu vaccination during 2014. The report described a medication error for FLUMIST QUADRIVALENT. The reported term was "used flumist quadrivalent with a history of allergic reaction to flu vaccine but had no problems (medication error)".  On 29-JAN-2018, the patient experienced the flu. Treatment with FLUMIST QUADRIVALENT (intranasal) was not changed.   The patient recovered from the event(s) of the flu on an unspecified date. The outcome of the event(s) of used flumist quadrivalent with a history of allergic reaction to flu vaccine but had no problems (medication error) was unknown. Additional description of the event(s) was as follows: allergic reactions to other flu vaccines and injectibles. The events were considered non-serious.
Since 12/17/2011 symptoms include:  Fatigue, malaise, dizziness, abdominal pain, pain in the back of the knees, cold intolerance, lightheaded, headache.
CMA gave an adult dose of Pfizer 0.3ml instead of the pediatric dose of 0.2ml
Information has been received from a physician concerning a 26 year old female who on 04-MAR-2008 was vaccinated with her first dose of Gardasil (Lot # not reported).  There was no concomitant medication.  On 05-MAR-2008 the patient developed a fever of 101.8F, malaise and weakness.  The patient had a CBC and comprehensive blood work (not further specified).  The patient is receiving aspirin (unspecified) for her symptoms.  The patient sought unspecified medical attention in the office.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 4/7/2008.  Initial and follow-up information has been received from a physician concerning a 26 year old female who on 04-MAR-2008 wsa vaccinated intramuscularly with her first dose of GARDASIL (Lot # 658219/0755U).  There was no concomitant medication.  On 05-MAR-2008 the patient developed a fever of 101.8F, malaise and weakness.  It was also reported that the patient developed a fever of 101.8F on 05-MAR-2008.  On 06-MAR-2008, the patient experienced a headache and a slight cough.  The patient ahd a CBC which was normal, a WBC of 8.6 and comprehensive blood work (not further specified).  The patient was receiving ASPIRIN (unspecified) for her symptoms.  The patient sought unspecified medical attention in the office.  On 07-MAR-2008, the patient recovered from the fever of 101.8F, malaise, weakness, headache and slight cough.  No additional information is expected.
Copious blood and mucous in stool (documented photographically) along with marked irritability occurring 76 hours after provision of rotavirus vaccine oral (vaccine given 2/12/16; symptoms 2/15/16).
Patient developed itchyness, redness, swelling, and pain to left arm subcutaneous. Area measured approximatly 2.5inches width and 2.5inches in lenght around site of injection.
Information has been received from a physician and a practice manager via company representative referring to a patient of unknown age and gender. On 25-MAR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23-10PK-0.5mlSD-PFS LLokwTip) (lot # K019386, expiration date 09-JUN-2016). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 384 hours with the lowest recorded temperature of 27 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported.
Extreme upper left calf cramping and muscle spasms, very painful and unlike any other typical cramp.  Will not release with usual cramp remedies - stretch, walk, etc.
24 hrs after injection mother noted red, raised area on Left shoulder.  No fever, no other signs or symptoms.  Left shoulder warm to touch, pink, enduration 4cm round area.  Temp. 97.8F
On Friday, 1/15/2021, I felt itching on and around the vaccine injection site. Looking at the site, I saw 4 inch bright red inflamed area. The inflamation is also warm to the touch. I contacted pharmacy, spoke with the pharmacist who suggested applying ice and taking an antihistamine. After applying ice, I only saw that the inflamed spot continued to spread down my left arm and is now about 4" by 6", still warm and red.
Sorethroat, sneezing, congestion, 99.9F temperature, scratchy throat, hoarseness, localized breakout L arm around vaccination site with itchiness, bump nickle size on L forearm. Signs and symptoms lasted for 6 days.
This spontaneous report as received from a nurse refers to a patient of unknown age. On 02-AUG-2012, the patient was vaccinated with the first dose of 0.5 ml GARDASIL (lot# unknown) intramuscular and on 30-JAN-2013, the patient received her second dose of 0.5 ml GARDASIL intramuscular. No other co-suspects were reported. No concomitant medications were reported. It was unknown if the patient had sought medical attention. The outcome and action taken was not provided. The reporter did not provide assessment of the relationship of the adverse event to the suspect therapy. Additional information has been requested.
Could hardly walk; Weak; Felt nauseated; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Could hardly walk), ASTHENIA (Weak), NAUSEA (Felt nauseated), HEADACHE (Headache) and PYREXIA (Fever) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced GAIT DISTURBANCE (Could hardly walk), ASTHENIA (Weak), NAUSEA (Felt nauseated), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, GAIT DISTURBANCE (Could hardly walk), ASTHENIA (Weak), NAUSEA (Felt nauseated), HEADACHE (Headache) and PYREXIA (Fever) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Tongue swelling; Tongue scratchy; Tongue burning as if ate hot soup; Tongue little bumpy; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 26Mar2021 at 12:45 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. It was unknown if the patient had any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication was not reported. On 12Apr2021, the patient experienced tongue swelling, scratchy, burning as if ate hot soup and little bumpy. It was reported that the patient did not check tongue until 15Apr2021 night and did have hot soup so didn't think much of it until she looked online because it persists. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tongue swelling, scratchy, burning as if ate hot soup and little bumpy was not resolved at the time of this report. The patient had received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 16Apr2021 at 16:15 (at the age of 50-year-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
After BEXSERO vaccine 4 hour later came with pain and swelling of the (R) upper arm extended to neck-swelling (R) shoulder. Supraclavicular lymphadenopathy.
Injection site became swollen, warm to touch, red, and painful. My upper arm felt a tight, burning sensation. As the day goes on, the sensation wears off but i can still minimally feel it.
pt recvd vax & exp chills, sweats, tightness at neck, back, shoulder & arm pain; pain at nape of neck & elboow w/ pressure in upper arm; nerve tingling & numbness;
Information has been received from a physician concerning a 11-year-old female who on 12-JAN-1998 was vaccinated with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (lot # 623654/0806E). On 27-NOV-2007, the patient developed more than 50 chicken pox lesions on her body even after being vaccinated. The patient sought unspecified medical attention. At the time of the report the patient's status was unknown. At the time of the report the patients status was unknown. A product quality complaint was not involved. Additional information has been requested.
Information has been received from a registered nurse with a public health department concerning a female student who on 6/18/04 was vaccinated with a dose of varicella virus vaccine live. The registered nurse reported that she was told by another schools' school nurse, that a female student developed a vesicular rash around her nipple. It was unknown as to whether the patient sought medical attention. There was no product quality complaint reported. Additional information has been requested.
Herpes type 1 that has been dormant for years appeared 6 days after vaccine; Disease Recurrence; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 17Apr2021 at 13:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included herpes type 1. The patient had known allergies to sulfa and latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications were not reported. On 22Apr2021, the patient experienced herpes type 1 that has been dormant for years appeared 6 days after vaccine. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were taken as a result of event and included treatment with acyclovir (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event herpes type 1 that has been dormant for years appeared 6 days after vaccine was recovering at the time of report.  No follow-up attempts are possible. No further information is expected.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 23-FEB-2015 the patient was vaccinated with an expired dose of ZOSTAVAX (lot # J014566, expiration date 18-FEB-2015, 0.65 ml, subcutaneous) (Expired drug administered). No adverse effect was reported. Additional information has been requested.
Pneumonia; Bronchitis; COVID-19 Positive; Missed the recommended interval between doses; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (Pneumonia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (Pneumonia) (seriousness criterion medically significant), BRONCHITIS (Bronchitis), COVID-19 (COVID-19 Positive) and PRODUCT DOSE OMISSION ISSUE (Missed the recommended interval between doses). At the time of the report, PNEUMONIA (Pneumonia), BRONCHITIS (Bronchitis) and COVID-19 (COVID-19 Positive) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Missed the recommended interval between doses) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information reported that, the patient got infusion in the hospital.  Company comment: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
After the 1st dose (3/29/2021), neck inflammation started on the right-side of the neck. The neck inflammation got worse after the 2nd dose (4/19/2021). The neck inflammation is still present.    Starting 5/11/2021: Intense adrenaline surges started happening every night between 3 am-7 am. My heart feels like it is beating extremely hard. I have checked my pulse and it is normal during the events (ranges from 65-90 bpm). I have checked blood pressure and it is usually in the 120/80 range (normal for me). However, there have been occasions where blood pressure drops to 100/70. These adrenaline surges and hard heart beats tend to get better if I stand up and move around. It will get worse again if I lay down. I have these on occasion during the day, but I am usually able to calm myself down. I have had scenarios where I feel fine during the day, but will lay down. The hard heart beats start almost immediately. I'm also exercise intolerant now. If I do anything more than a brisk walk, I feel very terrible and faint with a hard heart beat. One interesting data point, my father has the same symptoms and his started about the same general timeframe after his second dose of the Pfizer vaccine.
The pt experienced swelling of arm extending into shoulder and below elbow. Tingling of hand, sore shoulder and elbow. Hurt to move arm. Hand cold. Treated with cool compresses. Treated with ibuprofen.
expired Quadracel dose given to 4-year-old patient; Initial information received on 09-Aug-2019 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 4 years old male patient who received an expired 0.5 ml dose of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE lot C5222AA (Expiry date 23-Jun-2019) via intramuscular route in the right thigh on 08-Aug-2019.  It was a case of actual medication error due to expired vaccine used.  At a time of reporting no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Slept 24 hours after shot, headache, fever for 5 days.  Huge wave ran across body directly after administration.   Numbness in fingers ever since.  Loss of touch/feel in finger tips ever since.
When the doctor inserted the needle it disconnected from the hub of the syringe and all the vaccine dripped down patients arm. She removed the needle and gave a new dose in the opposite arm
Sudden onset vertigo and left ear hearing loss, resolved in 5min. 3 more bouts of same next day. On Monday, the 27th, sudden onset of vertigo and left ear hearing loss which is still unresolved.
bedridden; extreme nausea; headache; bodyache; stiffness; chest pain; dizzy whenever I try and stand/ light headed; can't focus on screen very long without feeling like throwing up; can barely turn neck; bones/joints hurt; bones/joints hurt; no energy; This is a spontaneous report from a contactable consumer (patient). A 32-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EW0191) via unspecified route of administration, administered in arm left on 01Jun2021 at 06:15 (at the age of 32-year-old) as 2nd dose, single dose for COVID-19 immunization. Medical history included allergy to peanuts and shellfish. Concomitant medication was not reported. The patient previously took bnt162b2 (lot number: EW0185) in arm left on 07May2021 at 07:15 as 1st dose, single dose for COVID-19 immunization and experienced bed ridden and fatigue. No other vaccines within 4 weeks prior to the COVID vaccine. On 02Jun2021 at 10:00 (AM), the patient experienced lightheaded, extreme nausea, physical weakness, headache and body ache. It was reported that the patient also experienced stiffness, chest pain, dizzy on same day. Whenever the patient was trying and stand, could not focus on screen very long without feeling like throwing up, always lightheaded, could barely turn neck, bones and joints hurt and no energy. The patient stated he received full-time care while bedridden first day and a half from his partner and continue to receive care daily as he was not able to accomplish much on his own at this point. The patient also stated he did not know if this was a permanent condition caused by the vaccine nor did he know what the extent of any permanent damage was. This was the worst body he had ever felt. The patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination. Patient was not tested COVID post vaccination. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Woke up following morning with the listed symptoms that increased in severity throughout the day. Hot and cold but no fever (moderate), Body aches all over (severe), Body sensitive to touch (severe), Muscle and joint pain (severe), Breasts extremely sensitive to touch/pressure (severe), Very sore arm at injection site (moderate), Low grade headache. All the above were resolved by the following day, which would be 2 days after the booster vaccine was administered. Basically, 24 hour reaction that caused me to lay down under blankets for the entire day. Was unable to sleep due to body aches and muscle/joint pain